Adherence and persistence

to preventive migraine treatments over 12 months follow-up for patients with migraine: calcitonin gene-related peptide monoclonal antibodies versus other preventive treatments

Total pain burden in patients

with previous failure of 2-4 migraine preventive medication categories: effects of galcanezumab in the CONQUER Phase 3b Trial

Annual indirect cost

savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trials

Functional REstoration with

rEyvow (FREE): a US-based cross-sectional survey in patients taking lasmiditan

©2022 | 2nd Dubai Neurology Hybrid Congress | All Rights Reserved | by MCO
error: Content is protected !!